Article

Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week from Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/biosimilar-naming-convention-debate-highlights-spe" target="_blank">View the story "Biosimilar Naming Convention Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos
Image credit: Photo18@desing | stock.dobe.com
Related Content
US FDA logo on smartphone -- Image credit: Luciano Luppa | stock.adobe.com
April 30th 2025

FDA Approves Nipocalimab-Aahu to Treat Patients With Generalized Myasthenia Gravis

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Assuring clients are informed. Shot of a young pharmacist helping an elderly customer at the prescription counter.
April 29th 2025

Asembia AXS25: Pharmacists Continue to Expand Clinical, Collaborative Role in Health Care

Luke Halpern, Assistant Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
Two African American pharmacists working in drugstore at hospital pharmacy | Image Credit: © AS Photo Family - stock.adobe.com
April 29th 2025

Asembia AXS25: Balancing Innovation With Affordability Crucial for Sustainable Rare Disease Economic Models

Luke Halpern, Assistant Editor
Portrait of a male pharmacist working at the counter in pharmacy | Image Credit: © Zamrznuti tonovi - stock.adobe.com
April 29th 2025

Asembia AXS25: Community Pharmacists Can Optimize Specialty Pharmacy Care

Luke Halpern, Assistant Editor